Aurobindo Pharma gets FDA approval for Valacyclovir tablets
Moneylife Digital Team 25 May 2010

Aurobindo Pharma Ltd has said that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Valacyclovir Hydrochloride tablets 500 mg (base) and 1 g (base).

Valacyclovir Hydrochloride tablets, which falls under the anti-infective therapeutic category are used for the treatment of cold sore, genital herpes and shingles in adult patients and chicken pox in pediatric patients 2-18 years of age.

On Tuesday Aurobindo Pharma shares ended 2.46% down at Rs847.80 on the Bombay Stock Exchange, while the benchmark Sensex closed 2.71% down at 16,022.48 points.

Comments
Array
Free Helpline
Legal Credit
Feedback